Smad5 regulates Akt2 expression and insulin-induced glucose uptake in L6 myotubes

Molecular and Cellular Endocrinology

Volumn 319, Issue 1-2, 2010, Pages 30-38

  Anhê, Fernando F ^a   Lellis Santos, Camilo ^a   Leite, Adriana R ^a   Hirabara, Sandro M ^b   Boschero, Antonio C ^c   Curi, Rui ^a   Anhê, Gabriel F ^c   Bordin, Silvana ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE CRUZEIRO DO SUL   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Akt2; Glucose uptake; Insulin action; Smad5

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; DEXAMETHASONE; INSULIN; PHOSPHATIDATE PHOSPHATASE; PROTEIN KINASE B BETA; SMAD5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; MALE; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SOLEUS MUSCLE; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; DEXAMETHASONE; GLUCOCORTICOIDS; GLUCOSE; IMMUNOPRECIPITATION; INSULIN; MALE; MUSCLE FIBERS, SKELETAL; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSFECTION;

EID: 77249137169     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.01.003     Document Type: Article

References (46)

1. Al-Khalili L., Chibalin A.V., Kannisto K., Zhang B.B., Permert J., Holman G.D., Ehrenborg E., Ding V.D., Zierath J.R., and Krook A. Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cell Mol. Life Sci. 60 (2003) 991-998
2. Anhê G.F., Hirabara S.M., Turrer T.C., Caperuto L.C., Anhê F.F., Ribeiro L.M., Marçal A.C., Carvalho C.R., Curi R., Machado U.F., and Bordin S. Postpartum glycemic homeostasis in early lactating rats is accompanied by transient and specific increase of soleus insulin response through IRS2/Akt pathway. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 (2007) 2225-2233
3. Bae S.S., Cho H., Mu J., and Birnbaum M.J. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 278 (2003) 49530-49536
4. Beguinot F., Kahn C.R., Moses A.C., and Smith R.J. Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells. J. Biol. Chem. 260 (1985) 15892-15898
5. Bordin S., Amaral M.E., Anhê G.F., Delghingaro-Augusto V., Cunha D.A., Nicoletti-Carvalho J.E., and Boschero A.C. Prolactin-modulated gene expression profiles in pancreatic islets from adult female rats. Mol. Cell Endocrinol. 220 (2004) 41-50
6. Bouzakri K., Zachrisson A., Al-Khalili L., Zhang B.B., Koistinen H.A., Krook A., and Zierath J.R. siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab. 4 (2006) 89-96
7. Brown M.A., Zhao Q., Baker K.A., Naik C., Chen C., Pukac L., Singh M., Tsareva T., Parice Y., Mahoney A., Roschke V., Sanyal I., and Choe S. Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J. Biol. Chem. 280 (2005) 25111-25118
8. Brozinick Jr. J.T., Robert B.R., and Dohm G.L. Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. Diabetes 52 (2003) 935-941
9. Caldefie-Chézet F., Moinard C., Minet-Quinard R., Gachon F., Cynober L., and Vasson M. Dexamethasone treatment induces long-lasting hyperleptinemia and anorexia in old rats. Metabolism 50 (2001) 1054-1058
10. Caperuto L.C., Anhê G.F., Cambiaghi T.D., Akamine E.H., do Carmo Buonfiglio D., Cipolla-Neto J., Curi R., and Bordin S. Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulin-sensitizing substance. Endocrinology 149 (2008) 6326-6335
11. Chen C., Grzegorzewski K.J., Barash S., Zhao Q., Schneider H., Wang Q., Singh M., Pukac L., Bell A.C., Duan R., Coleman T., Duttaroy A., Cheng S., Hirsch J., Zhang L., Lazard Y., Fischer C., Barber M.C., Ma Z.D., Zhang Y.Q., Reavey P., Zhong L., Teng B., Sanyal I., Ruben S.M., Blondel O., and Birse C.E. An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat. Biotechnol. 21 (2003) 294-301
12. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw III E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., and Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292 (2001) 1728-1731
13. Cho H., Thorvaldsen J.L., Chu Q., Feng F., and Birnbaum M.J. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276 (2001) 38349-38352
14. David L., Mallet C., Mazerbourg S., Feige J.J., and Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109 (2007) 1953-1961
15. Dummler B., Tschopp O., Hynx D., Yang Z.Z., Dirnhofer S., and Hemmings B.A. Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol. Cell Biol. 26 (2006) 8042-8051
16. Ewart H.S., Somwar R., and Klip A. Dexamethasone stimulates the expression of GLUT1 and GLUT4 proteins via different signalling pathways in L6 skeletal muscle cells. FEBS Lett. 425 (1998) 179-183
17. Gosmanov A.R., Umpierrez G.E., Karabell A.H., Cuervo R., and Thomason D.B. Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E8-E15
18. Haber R.S., and Weinstein S.P. Role of glucose transporters in glucocorticoid-induced insulin resistance. GLUT4 isoform in rat skeletal muscle is not decreased by dexamethasone. Diabetes 41 (1992) 728-735
19. Ikubo M., Wada T., Fukui K., Ishiki M., Ishihara H., Asano T., Tsuneki H., and Sasaoka T. Impact of lipid phosphatases SHIP2 and PTEN on the time- and Akt-isoform-specific amelioration of TNF-alpha-induced insulin resistance in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 296 (2009) E157-E164
20. Ishihara H., Sasaoka T., Hori H., Wada T., Hirai H., Haruta T., Langlois W.J., and Kobayashi M. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling. Biochem. Biophys. Res. Commun. 260 (1999) 265-272
21. Kaneko S., Feldman R.I., Yu L., Wu Z., Gritsko T., Shelley S.A., Nicosia S.V., Nobori T., and Cheng J.Q. Positive feedback regulation between Akt2 and MyoD during muscle differentiation. Cloning of Akt2 promoter. J. Biol. Chem. 277 (2002) 23230-23235
22. Katagiri T., Imada M., Yanai T., Suda T., Takahashi N., and Kamijo R. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7 (2002) 949-960
23. Klip A. The many ways to regulate glucose transporter 4. Appl. Physiol. Nutr. Metab. 34 (2009) 481-487
24. Korchynskyi O., and ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277 (2002) 4883-4891
25. Lautt W.W. The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can. J. Physiol. Pharmacol. 77 (1999) 553-562
26. Lawson M.A., and Purslow P.P. Differentiation of myoblasts in serum-free media: effects of modified media are cell line-specific. Cells Tissues Organs 167 (2000) 130-137
27. Li W., Chen F., Nagarajan R.P., Liu X., and Chen Y. Characterization of the DNA-binding property of Smad5. Biochem. Biophys. Res. Commun. 286 (2001) 1163-1169
28. Maehama T., and Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273 (1998) 13375-13378
29. Massague J., Seoane J., and Wotton D. Smad transcription factors. Genes Dev. 19 (2005) 2783-2810
30. McCurdy C.E., and Cartee G.D. Akt2 is essential for the full effect of calorie restriction on insulin-stimulated glucose uptake in skeletal muscle. Diabetes 54 (2005) 1349-1356
31. Miller A.F., Harvey S.A., Thies R.S., and Olson M.S. Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. J. Biol. Chem. 275 (2000) 17937-17945
32. Mitsumoto Y., Burdett E., Grant A., and Klip A. Differential expression of the GLUT1 and GLUT4 glucose transporters during differentiation of L6 muscle cells. Biochem. Biophys. Res. Commun. 175 (1991) 652-659
33. Miyazono K., and Miyazawa K. Id: a target of BMP signaling. Sci. STKE 151 (2002) PE40
34. Nerlov C. C/EBPs: recipients of extracellular signals through proteome modulation. Curr. Opin. Cell Biol. 20 (2008) 180-185
35. Ning K., Miller L.C., Laidlaw H.A., Burgess L.A., Perera N.M., Downes C.P., Leslie N.R., and Ashford M.L. A novel leptin signalling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic beta-cells. EMBO J. 25 (2006) 2377-2387
36. Noda S., Kishi K., Yuasa T., Hayashi H., Ohnishi T., Miyata I., Nishitani H., and Ebina Y. Overexpression of wild-type Akt1 promoted insulin-stimulated p70S6 kinase (p70S6K) activity and affected GSK3 beta regulation, but did not promote insulin-stimulated GLUT4 translocation or glucose transport in L6 myotubes. J. Med. Invest. 47 (2000) 47-55
37. Rotwein P., and Wilson E.M. Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation. J. Cell Physiol. 219 (2009) 503-511
38. Sasaki A., Masuda Y., Ohta Y., Ikeda K., and Watanabe K. Filamin associates with Smads and regulates transforming growth factor-beta signaling. J. Biol. Chem. 276 (2001) 17871-17877
39. Scharpfenecker M., van Dinther M., Liu Z., van Bezooijen R.L., Zhao Q., Pukac L., Löwik C.W., and ten Dijke P. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J. Cell Sci. 120 (2007) 964-972
40. Sleeman M.W., Wortley K.E., Lai K.M., Gowen L.C., Kintner J., Kline W.O., Garcia K., Stitt T.N., Yancopoulos G.D., Wiegand S.J., and Glass D.J. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat. Med. 11 (2005) 199-205
41. Taniguchi C.M., Emanuelli B., and Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7 (2006) 85-96
42. Tong P., Khayat Z.A., Huang C., Patel N., Ueyama A., and Klip A. Insulin-induced cortical actin remodeling promotes GLUT4 insertion at muscle cell membrane ruffles. J. Clin. Invest. 108 (2001) 371-381
43. Tsuchida K., Nakatani M., Uezumi A., Murakami T., and Cui X. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer. Endocr. J. 55 (2008) 11-21
44. von Bubnoff A., and Cho K.W. Intracellular BMP signaling regulation in vertebrates: pathway or network?. Dev. Biol. 239 (2001) 1-14
45. Wijesekara N., Konrad D., Eweida M., Jefferies C., Liadis N., Giacca A., Crackower M., Suzuki A., Mak T.W., Kahn C.R., Klip A., and Woo M. Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol. Cell Biol. 25 (2005) 1135-1145
46. Zwijsen A., Verschueren K., and Huylebroeck D. New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Lett. 546 (2003) 133-139